Details for Patent: 11,357,935

Which drugs does patent 11,357,935 protect, and when does it expire?

Patent 11,357,935 protects PROAIR DIGIHALER, AIRDUO DIGIHALER, and ARMONAIR DIGIHALER, and is included in three NDAs.

Protection for ARMONAIR DIGIHALER has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-eight patent family members in thirteen countries.

Summary for Patent: 11,357,935

Patent landscape, scope, and claims:

Title:	Drug delivery device with electronics
Abstract:	A system may include a mobile application residing on an external device and an inhalation device. The inhalation device may include a mouthpiece, a mouthpiece cover, medicament, and an electronics module comprising a processor. The inhalation device may be configured to both prepare a dose of medicament for delivery to a user and cause the processor to transition between power states when the mouthpiece cover is moved from a closed position to an open position to expose the mouthpiece. The electronics module or the mobile application may be configured to generate usage events based on usage of the inhalation device by the user. The electronics module may also include a pressure sensor, and the electronics module or the mobile application may be configured to determine whether a usage event is a good inhalation event, a fair inhalation event, or a no inhalation event based on feedback from the pressure sensor.
Inventor(s):	Calderon Oliveras; Enrique (Barcelona, ES), Lewis; Carl L. (Cambridgeshire, GB), Cotton; Symon D'Oyly (Cambridge, GB), Gardner; Steven D. (Peterborough, GB), Kivlin; Robert O. (Cambridge, GB), Zur; Amir (Cambridge, MA)
Assignee:	Norton (Waterford) Limited (Waterford, IE)
Application Number:	16/421,451
Patent Claim Types: see list of patent claims	Delivery; Device;

Drugs Protected by US Patent 11,357,935

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Teva Branded Pharm	PROAIR DIGIHALER	albuterol sulfate	POWDER, METERED;INHALATION	205636-002	Dec 21, 2018		DISCN	Yes	No			Y
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-004	Jul 12, 2019		DISCN	Yes	No			Y
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-005	Jul 12, 2019		DISCN	Yes	No			Y
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-006	Jul 12, 2019		DISCN	Yes	No			Y

International Family Members for US Patent 11,357,935

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017361878
Australia	2022263489
Canada	3043965
China	110167619